![David J. Valacer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di David J. Valacer
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a David J. Valacer tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Seaview Securities LLC
![]() Seaview Securities LLC Investment Banks/BrokersFinance Seaview Securities LLC provides investment banking services focused on the life sciences industry. The firm's services include private placements, mergers & acquisitions, financial and business strategy advisory, and underwriting services. The company was founded in January 2002 by Russell L. Pollack and Joseph P. Dougherty and is headquartered in New York, NY. | Investment Banks/Brokers | Founder | |
CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
Epiphany Biosciences, Inc.
![]() Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Epiphany Biosciences, Inc. develops therapeutic products and diagnostic technologies that treat and prevent the spread of pathogenic viruses. The firm develops therapeutics to prevent spread of varicella zoster virus (VZV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV). The company was founded by David C Myles, Robert Charles Gallo, Harold E Selick and Frederick Volinsky in 2001 and is headquartered in San Francisco, CA. | Medical Specialties | Founder | |
TRICIDA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sofinnova Investments, Inc.
![]() Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | General Counsel | |
Affymax Research Institute
![]() Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Affymax Research Institute is a company that researches and develops pharmaceutical products. The company is based in Palo Alto, CA. Affymax Research Institute was acquired by Affymax, Inc. from GSK Plc on July 30, 2001. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
ArQule UK Ltd.
![]() ArQule UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Galapagos NV, ArQule UK Ltd. is a company that discovers and produces novel chemical compounds with commercial potential. ArQule UK Ltd. is based in Cambridge, UK. ArQule was acquired by Galapagos Biotech Ltd., a subsidiary of Galapagos NV from ArQule, Inc. on June 23, 2003. The British company was founded by Harold E. Selick. | Pharmaceuticals: Major | Founder | |
Fish & Neave LLP
![]() Fish & Neave LLP Miscellaneous Commercial ServicesCommercial Services Fish & Neave operates as a law firm. It specializes in specializes in intellectual property issues involving patents, trademarks, and copyrights. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Tulane University (Louisiana) | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Undergraduate Degree | |
Gemin X Pharmaceuticals US, Inc.
![]() Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Director/Board Member | |
St. Jude Children's Research Hospital, Inc.
![]() St. Jude Children's Research Hospital, Inc. Hospital/Nursing ManagementHealth Services St. Jude Children's Research Hospital, Inc. offers health care and social assistance services for children. It is internationally recognized for its pioneering research and treatment for children with cancer and other catastrophic diseases. The firm's treatment programs include brain tumors, leukemia, lymphoma, infectious diseases, immunodeficiency diseases, blood disorders, sickle cell disease, and solid tumors. The company was founded by Danny Thomas on February 4, 1962 and is headquartered in Memphis, TN. | Hospital/Nursing Management | Director/Board Member | |
Takeda Pharmaceuticals U.S.A., Inc.
![]() Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
PREDICTIVE ONCOLOGY INC. | Medical Specialties | Director/Board Member | |
Lehman Brothers, Inc. /Istanbul Division/ | Investment Managers | Corporate Officer/Principal | |
Amunix, Inc.
![]() Amunix, Inc. Pharmaceuticals: MajorHealth Technology Amunix, Inc. develops protein pharmaceuticals. It offers XTEN which is hydrophilic, unstructured, biodegradable polypeptides that impart a number of favorable properties upon the molecules to which they are attached. The company was founded by Volker Schellenberger and Willem Stemmer in 2006 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
Harvard Medical School | College/University | Doctorate Degree | |
Mission Bay Capital Management, Inc.
![]() Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
The University of Chicago Booth School of Business | College/University | Masters Business Admin | |
Caxton Alternative Management LP
![]() Caxton Alternative Management LP Investment ManagersFinance Caxton Alternative Management LP (do-business-as CAM Capital) is a single-family office which was founded in 2012 by Bruce Kovner following his retirement from Caxton Associates, the macro hedge fund he founded and managed from 1983 to 2011. Headquartered in New York City, CAM Capital manages assets exclusively for entities related to Mr. Kovner and its senior employees. | Investment Managers | Chief Executive Officer | |
Ropes & Gray LLP
![]() Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Valence Life Sciences LLC
![]() Valence Life Sciences LLC Investment ManagersFinance Valence Life Sciences LLC (Valence Life Sciences) is an venture capital firm founded in 2012 by Rachel Anne Leheny and Eric Wayne Roberts. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Harvard Business School | College/University | Masters Business Admin | |
Fordham University School of Law | College/University | Graduate Degree | |
BA Ruskin Law, LLC | President | ||
POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Inflazome Ltd.
![]() Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Camitro UK Ltd.
![]() Camitro UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Camitro UK Ltd. is a company that operates commercial research institutions. The company is based in Cambridge, UK. The British company was founded by Harold E. Selick. | Miscellaneous Commercial Services | Founder | |
Palvella Therapeutics, Inc.
![]() Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Biotechnology | Director/Board Member | |
Primmune Therapeutics, Inc.
![]() Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Amunix Pharmaceuticals, Inc.
![]() Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member Director/Board Member | |
VIRPAX PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Antios Therapeutics, Inc.
![]() Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member | |
Burke Neurological Institute | Director/Board Member | ||
Molecular Templates OpCo, Inc.
![]() Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Avenge Bio, Inc.
![]() Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Alpha-9 Oncology, Inc.
![]() Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 43 |
Regno Unito | 5 |
Turchia | 2 |
Norvegia | 2 |
Irlanda | 2 |
Settori
Health Technology | 23 |
Finance | 11 |
Consumer Services | 9 |
Commercial Services | 8 |
Health Services | 2 |
Posizioni
Director/Board Member | 40 |
Independent Dir/Board Member | 13 |
Chairman | 12 |
Corporate Officer/Principal | 10 |
Chief Executive Officer | 7 |
Contatti più connessi
Insiders | |
---|---|
Harold Selick | 24 |
David Hirsch | 20 |
Scott Morenstein | 17 |
Barbara Ruskin | 12 |
David Hoffmann | 10 |
Michael Broxson | 6 |
- Borsa valori
- Insiders
- David J. Valacer
- Connessioni Società